Tolerability of nausea and vomiting and associations with weight loss in a randomized trial of liraglutide in obese, non-diabetic adults. [electronic resource]
- International journal of obesity (2005) May 2014
- 689-97 p. digital
Adolescent Adult Aged Anti-Obesity Agents--adverse effects Body Mass Index Dose-Response Relationship, Drug Double-Blind Method Drug Administration Schedule Europe--epidemiology Female Glucagon-Like Peptide 1--adverse effects Humans Liraglutide Male Middle Aged Nausea--chemically induced Obesity--drug therapy Quality of Life Severity of Illness Index Treatment Outcome Vomiting--chemically induced Weight Loss--drug effects